Norm- and hypo-fractionated radiotherapy is capable of activating human dendritic cells.

Despite the transient immunosuppressive properties of local radiotherapy (RT), this classical treatment modality of solid tumors is capable of inducing immunostimulatory forms of tumor-cell death. The resulting 'immunotoxicity' in the tumor, but not in healthy tissues, may finally lead to immune-mediated destruction of the tumor. However, little is known about the best irradiation scheme in this setting.

Antitumor immune responses induced by ionizing irradiation and further immune stimulation.

The therapy of cancer emerged as multimodal treatment strategy. The major mode of action of locally applied radiotherapy (RT) is the induction of DNA damage that triggers a network of events that finally leads to tumor cell cycle arrest and cell death. Along with this, RT modifies the phenotype of the tumor cells and their microenvironment.

How does ionizing irradiation contribute to the induction of anti-tumor immunity?

Radiotherapy (RT) with ionizing irradiation is commonly used to locally attack tumors. It induces a stop of cancer cell proliferation and finally leads to tumor cell death. During the last years it has become more and more evident that besides a timely and locally restricted radiation-induced immune suppression, a specific immune activation against the tumor and its metastases is achievable by rendering the tumor cells visible for immune attack.

MR imaging for the detection of endoleaks in recipients of abdominal aortic stent-grafts with low magnetic susceptibility.

Rationale And Objectives: This study was performed to assess the efficacy of magnetic resonance (MR) imaging for the detection of endoleaks in recipients of abdominal aortic stent-grafts with low magnetic susceptibility.

Materials And Methods: A retrospective search was conducted in radiology department records for cases of patients with low-susceptibility stent-grafts who had been evaluated with MR imaging and either computed tomography (CT) or conventional angiography within a 1-month time frame. Any endoleaks previously confirmed and classified with the use of CT and/or conventional angiography were compared with findings from MR imaging.

Prophylactic treatment of severe factor X deficiency with prothrombin complex concentrate.

Factor X (FX) deficiency is an autosomal recessive trait that occurs in fewer than 1 in 500 000 people. Not surprisingly, reports of prophylactic treatment for FX deficiency are exceedingly rare. We now report our experience of the use of prophylactic therapy in a FX-deficient patient.